Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use BYQLOVI ®safely and effectively. See full prescribing information for BYQLOVI. BYQLOVI (clobetasol propionate ophthalmic suspension) 0.05%, for topical ophthalmic use Initial U.S. Approval: 1985
Medication labelWhy this: Advisory · dailymed-prescription
BYQLOVI is indicated for the treatment of post-operative inflammation and pain following ocular surgery.
- generic_name
- clobetasol propionate
- product_names
- clobetasol propionate
- ndc
- 82667-021, 82667-021-05, 82667-021-00
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en